Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria

Atherosclerosis

Volumn 122, Issue 1, 1996, Pages 69-77

  Tsai, Michael Y ^a   Garg, Uttam ^a   Key, Nigel S ^a   Hanson, Naomi Q ^a   Suh, Anne ^a   Schwichtenberg, Kerry ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Amplification refractory mutation system; Cystathionine synthase; Genetic variants; Homocystinuria; Hyperhomocyst(e)inemia

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTINE; METHIONINE;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENZYME ACTIVITY; FEMALE; GENETICS; HETEROZYGOTE; HOMOCYSTEINE URINE LEVEL; HUMAN; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SKIN FIBROBLAST; VASCULAR DISEASE;

EID: 0029903031     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05748-X     Document Type: Article

References (16)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl J Med 1991;324:1149.
2. Selhub J, Jacques PF, Bostom AG, Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer ES, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. New Engl J Med 1995;332:286.
3. Engbersen AMT, Franken DG, Boers GH, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenete-trahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142.
4. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New Engl J Med 1985;313:709.
5. Boers GHJ, Fowler B, Smals AGH, Trijbeis FJM, Leermakers AI, Kleijer WJ, Kloppenborg PWC. Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet 1985;69:164.
6. Kozich V, Kraus JP. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine β-synthase deficiency. Hum Mutat 1992;1:113.
7. Kraus JP, Le K, Swaroop M, Ohura T, Tahara T, Rosenberg L, Roper MD, Kozich V. Human cystathionine β-synthase cDNA: sequence, alternate splicing and expression in cultured cells. Hum Mol Genet 1993;2:1633.
8. Kraus JP. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis 1994;17:383.
9. Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. Molecular basis of cystathionine β-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 1993;2:1857.
10. Kraus JP. Cystathionine β-synthase (Human). Methods Enzymol 1987;143:388.
11. Mudd SH. Vascular disease and homocysteine metabolism (editorial). New Engl J Med 1985;313:751.
12. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Diseases. New York: McGraw-Hill, 1989;693.
13. Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystin-uria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995;56:1324.
14. Shih VE, Fringer JM, Mandell R, Kraus JP, Berry GT, Heidenreich RA, Korson MS, Levy HL. Ramesh V. A missense mutation (I278T) in the cystathionine β-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet 1995;57:34.
15. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutaiton in DNA, The amplification refractory mutation system. Nucleic Acids Res 1989;17:2503.
16. Tsai MY, Hanson NQ, Copeland KR, Beheshti J, Garg U. Determination of a T/G polymorphism at nucleotide 3206 of the apolipoprotein C III gene by amplification refractory mutation system. Clin Chem 1994;40:2235.